Atypical liquidation preference rights on the rise
An increasing percentage of late-stage deals have atypical liquidation preference rights, according to Aumni-tracked venture transactions.
Among late-stage equity financings (series C+), there’s been uptick in the frequency of transactions with a liquidation preference multiplier of greater than 1x. The level has risen to ~13% as of June, implying investors are achieving greater protective measures in late-stage transactions. This is the highest level seen in more than 5-years.
The sharp upwards trajectory in late-stage stands in contrast to early-stage, where the prevalence of deals with atypical liquidation preferences has stabilized at around 3% over the last few months.
.jpeg)
For background, liquidation preferences determine the payout order and amount investors receive in a liquidation event, such as an exit, sale or bankruptcy. It stipulates, in the case where preferred shares do not convert to common upon exit, how much the fund’s initial investment will payout ahead of common shareholders, such as founders or employees. A 1x liquidation preference is considered typical in venture. In the case of a 1x liquidation preference, a fund is entitled to the amount equal to its initial investment before the remaining exit value is distributed to common shareholders. Liquidation preferences greater than 1x entitle investors to a multiple of their initial investment, ahead of common shareholders.
A rise in the prevalence of atypical liquidation rights may reflect more cautious late stage investor sentiment, with investors seeking stronger protections and returns in exchange for their participation.
Aumni will continue to monitor these trends.
Want to see more venture data? Check out our Market Insights offering.
©2023 JPMorgan Chase & Co. All rights reserved. JPMorgan Chase Bank, N.A. Member FDIC.
This material is not the product of J.P. Morgan’s Research Department. It is not a research report and is not intended as such. This material is provided for informational purposes only and is subject to change without notice. It is not intended as research, a recommendation, advice, offer or solicitation to buy or sell any financial product or service, or to be used in any way for evaluating the merits of participating in any transaction. Please consult your own advisors regarding legal, tax, accounting or any other aspects including suitability implications, for your particular circumstances or transactions. J.P. Morgan and its third-party suppliers disclaim any responsibility or liability whatsoever for the quality, fitness for a particular purpose, non-infringement, accuracy, currency or completeness of the information herein, and for any reliance on, or use of this material in any way. Any information or analysis in this material purporting to convey, summarize, or otherwise rely on data may be based on a sample or normalized set thereof. This material is provided on a confidential basis and may not be reproduced, redistributed or transmitted, in whole or in part, without the prior written consent of J.P. Morgan. Any unauthorized use is strictly prohibited. Any product names, company names and logos mentioned or included herein are trademarks or registered trademarks of their respective owners.
Aumni, Inc. (“Aumni”) is a wholly-owned subsidiary of JPMorgan Chase & Co. Access to the Aumni platform is subject to execution of an applicable platform agreement and order form and access will be granted by J.P. Morgan in its sole discretion. J.P. Morgan is the global brand name for JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide. Aumni does not provide any accounting, regulatory, tax, insurance, investment, or legal advice. The recipient of any information provided by Aumni must make an independent assessment of any legal, credit, tax, insurance, regulatory and accounting issues with its own professional advisors in the context of its particular circumstances. Aumni is neither a broker-dealer nor a member of any exchanges or self-regulatory organizations.
383 Madison Ave, New York, NY 10017
